Good morning my FRiends,
Thought the following information might be of some interest.
Avigen, Inc. today announced commencement of a Phase I human clinical
trial of Coagulin-B , its adeno-associated virus based gene therapy
treatment for hemophilia B. This clinical trial marks the first attempt
to treat hemophilia B using gene therapy and the first attempt ... [PR
Newswire]
God Bless All,
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
